Fed. Cir.

Allergan Sales, LLC v. Sandoz, Inc., No. 17-1499 (Fed. Cir. Dec. 22, 2017)

Errata

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 17-1499
Also Docketed: No. 17-1500, No. 17-1558, No. 17-1559 (consolidated; same document)
Decided: December 22, 2017
Judge: —
Document: Errata
Length: 1 page

Full Text Analysis Cite this Opinion

Download Opinion (PDF)

United States Court of Appeals

for the Federal Circuit

January 2, 2018

ERRATUM

Appeal Nos. 2017-1499, 2017-1500, 2017-1558, 2017-1559

ALLERGAN SALES, LLC,

Plaintiff-Cross-Appellant

SANDOZ, INC., ALCON LABORATORIES, INC.,

ALCON RESEARCH, LTD.,

Defendants-Appellants

Decided: December 22, 2017

Nonprecedential Opinion

Please make the following change: On page 8, line 34, replace “titrate” with “tartrate.”

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Allergan Sales, LLC v. Sandoz, Inc., No. 17-1499 (Fed. Cir. Dec. 22, 2017).

govinfo ID: USCOURTS-ca13-17-01499-1
Permalink: https://patentcasewatch.com/opinions/USCOURTS-ca13-17-01499-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: govinfo.gov USCOURTS collection · retrieved July 25, 2026 · Report an error